Assessment of Psychosocial and Neonatal Risk Factors for Trajectories of Behavioral Dysregulation Among Young Children From 18 to 72 Months of Age.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
03 04 2023
03 04 2023
Historique:
medline:
28
4
2023
pubmed:
26
4
2023
entrez:
26
4
2023
Statut:
epublish
Résumé
Emotional and behavioral dysregulation during early childhood are associated with severe psychiatric, behavioral, and cognitive disorders through adulthood. Identifying the earliest antecedents of persisting emotional and behavioral dysregulation can inform risk detection practices and targeted interventions to promote adaptive developmental trajectories among at-risk children. To characterize children's emotional and behavioral regulation trajectories and examine risk factors associated with persisting dysregulation across early childhood. This cohort study examined data from 20 United States cohorts participating in Environmental influences on Child Health Outcomes, which included 3934 mother-child pairs (singleton births) from 1990 to 2019. Statistical analysis was performed from January to August 2022. Standardized self-reports and medical data ascertained maternal, child, and environmental characteristics, including prenatal substance exposures, preterm birth, and multiple psychosocial adversities. Child Behavior Checklist caregiver reports at 18 to 72 months of age, with Dysregulation Profile (CBCL-DP = sum of anxiety/depression, attention, and aggression). The sample included 3934 mother-child pairs studied at 18 to 72 months. Among the mothers, 718 (18.7%) were Hispanic, 275 (7.2%) were non-Hispanic Asian, 1220 (31.8%) were non-Hispanic Black, 1412 (36.9%) were non-Hispanic White; 3501 (89.7%) were at least 21 years of age at delivery. Among the children, 2093 (53.2%) were male, 1178 of 2143 with Psychosocial Adversity Index [PAI] data (55.0%) experienced multiple psychosocial adversities, 1148 (29.2%) were exposed prenatally to at least 1 psychoactive substance, and 3066 (80.2%) were term-born (≥37 weeks' gestation). Growth mixture modeling characterized a 3-class CBCL-DP trajectory model: high and increasing (2.3% [n = 89]), borderline and stable (12.3% [n = 479]), and low and decreasing (85.6% [n = 3366]). Children in high and borderline dysregulation trajectories had more prevalent maternal psychological challenges (29.4%-50.0%). Multinomial logistic regression analyses indicated that children born preterm were more likely to be in the high dysregulation trajectory (adjusted odds ratio [aOR], 2.76; 95% CI, 2.08-3.65; P < .001) or borderline dysregulation trajectory (aOR, 1.36; 95% CI, 1.06-1.76; P = .02) vs low dysregulation trajectory. High vs low dysregulation trajectories were less prevalent for girls compared with boys (aOR, 0.60; 95% CI, 0.36-1.01; P = .05) and children with lower PAI (aOR, 1.94; 95% CI, 1.51-2.49; P < .001). Combined increases in PAI and prenatal substance exposures were associated with increased odds of high vs borderline dysregulation (aOR, 1.28; 95% CI, 1.08-1.53; P = .006) and decreased odds of low vs high dysregulation (aOR, 0.77; 95% CI, 0.64-0.92; P = .005). In this cohort study of behavioral dysregulation trajectories, associations were found with early risk factors. These findings may inform screening and diagnostic practices for addressing observed precursors of persisting dysregulation as they emerge among at-risk children.
Identifiants
pubmed: 37099294
pii: 2804211
doi: 10.1001/jamanetworkopen.2023.10059
pmc: PMC10134008
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2310059Subventions
Organisme : NIH HHS
ID : UH3 OD023249
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023320
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023271
Pays : United States
Organisme : NIH HHS
ID : UG3 OD023271
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023272
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023342
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023348
Pays : United States
Organisme : NIH HHS
ID : U2C OD023375
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023349
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023285
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023288
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023337
Pays : United States
Organisme : NIH HHS
ID : U24 OD023382
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023389
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023318
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023347
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023279
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023282
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023328
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023289
Pays : United States
Organisme : NIH HHS
ID : U24 OD023319
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023313
Pays : United States
Investigateurs
Phillip B Smith
(PB)
Laura K Newby
(LK)
Lisa P Jacobson
(LP)
Diane J Catellier
(DJ)
Richard C Gershon
(RC)
David Cella
(D)
Susan L Teitelbaum
(SL)
Annemarie Stroustrup
(A)
Andrea L Lampland
(AL)
Mark L Hudak
(ML)
Dennis E Mayock
(DE)
Lisa K Washburn
(LK)
Cristiane Duarte
(C)
Glorisa J Canino
(GJ)
Assiamira M Ferrara
(AM)
Caherine J Karr
(CJ)
Alex Mason
(A)
Carmen J Marsit
(CJ)
Steven L Pastyrnak
(SL)
Charles Neal
(C)
Brian S Carter
(BS)
Jennifer B Helderman
(JB)
Jody M Ganiban
(JM)
Thomas G O'Connor
(TG)
Hyagriv Simhan
(H)
Jean Kerver
(J)
Charles Barone
(C)
Patricia McKane
(P)
Nigel Paneth
(N)
Michael R Elliott
(MR)
Susan L Schantz
(SL)
Robert M Silver
(RM)
Rosalind J Wright
(RJ)
Michelle Bosquet-Enlow
(M)
Joanna A Maselko
(JA)
Références
J Dev Behav Pediatr. 2020 Dec;41(9):698-705
pubmed: 32740284
Drug Alcohol Depend. 2022 Mar 1;232:109252
pubmed: 35032855
Psychol Assess. 2014 Jun;26(2):513-27
pubmed: 24548149
Neurotoxicol Teratol. 2000 May-Jun;22(3):325-36
pubmed: 10840176
Drug Alcohol Depend. 2021 Jan 1;218:108411
pubmed: 33272717
J Child Psychol Psychiatry. 2012 Sep;53(9):918-26
pubmed: 22409304
Am J Obstet Gynecol. 2018 Feb;218(2S):S630-S640
pubmed: 29422205
EClinicalMedicine. 2021 Nov 27;42:101216
pubmed: 34901794
J Clin Psychiatry. 2009 Apr 21;70(5):732-40
pubmed: 19389330
J Child Psychol Psychiatry. 2015 Nov;56(11):1202-11
pubmed: 25763525
J Marital Fam Ther. 2022 Jan;48(1):23-55
pubmed: 34783041
Curr Drug Abuse Rev. 2012 Jun;5(2):135-47
pubmed: 22455509
J Abnorm Child Psychol. 2019 Nov;47(11):1785-1798
pubmed: 31069583
Curr Opin Pediatr. 2018 Apr;30(2):260-262
pubmed: 29356702
Depress Anxiety. 2021 Oct;38(10):1034-1045
pubmed: 34370895
Eur Child Adolesc Psychiatry. 2022 Feb;31(2):313-324
pubmed: 33386524
JAMA Pediatr. 2021 Nov 1;175(11):1142-1150
pubmed: 34369987
Arch Womens Ment Health. 2022 Aug;25(4):807-817
pubmed: 35708790
Semin Fetal Neonatal Med. 2014 Apr;19(2):97-104
pubmed: 24290907
Nicotine Tob Res. 2009 Oct;11(10):1166-74
pubmed: 19640836
J Clin Child Adolesc Psychol. 2021 Sep-Oct;50(5):551-564
pubmed: 31914322
J Affect Disord. 2009 Mar;113(3):227-35
pubmed: 18632161
J Am Acad Child Adolesc Psychiatry. 2015 Oct;54(10):816-23
pubmed: 26407491
JAMA Netw Open. 2022 Apr 1;5(4):e225972
pubmed: 35380644
Psychol Sci. 2012 Sep 1;23(9):979-83
pubmed: 22825357
Dev Psychol. 2014 May;50(5):1482-1496
pubmed: 24447116
Biol Psychiatry. 2006 Nov 1;60(9):903-11
pubmed: 16650832
Eur J Psychotraumatol. 2020 Nov 10;11(1):1822064
pubmed: 33244362
J Perinatol. 2020 Jul;40(7):1056-1065
pubmed: 32444681
Eur Child Adolesc Psychiatry. 2019 Apr;28(4):531-542
pubmed: 30191335
Dev Med Child Neurol. 2013 Sep;55(9):788-96
pubmed: 23521214
N Engl J Med. 2016 Jun 9;374(23):2201-5
pubmed: 27276559
Appl Psychol Meas. 2021 Jul;45(5):386-388
pubmed: 34565942
J Child Psychol Psychiatry. 2011 Feb;52(2):139-47
pubmed: 20854363
Pediatrics. 2007 Feb;119(2):e348-59
pubmed: 17272597
J Clin Child Psychol. 2001 Sep;30(3):327-37
pubmed: 11501250
Obstet Gynecol. 2018 Sep;132(3):784-785
pubmed: 30134408
J Am Acad Child Adolesc Psychiatry. 2010 Nov;49(11):1105-16
pubmed: 20970698
Curr Psychiatry Rep. 2015 Feb;17(2):5
pubmed: 25617041
Pediatrics. 2013 Mar;131(3):e1009-24
pubmed: 23439891
Am J Epidemiol. 2023 Mar 24;:
pubmed: 36963379
J Addict Med. 2017 May/Jun;11(3):178-190
pubmed: 28406856
Drug Alcohol Depend. 2018 Nov 1;192:223-232
pubmed: 30273890
J Affect Disord. 2020 Apr 1;266:100-108
pubmed: 32056864
Addiction. 2008 Jun;103(6):1039-47
pubmed: 18373724
Int J Environ Res Public Health. 2019 Apr 21;16(8):
pubmed: 31010090
JAMA Pediatr. 2023 Mar 1;177(3):231-239
pubmed: 36622653
Drug Alcohol Depend. 2018 Apr 1;185:82-92
pubmed: 29428324
PLoS One. 2019 Nov 6;14(11):e0223690
pubmed: 31693682
Dev Psychopathol. 2014 May;26(2):393-403
pubmed: 24621564
J Am Acad Child Adolesc Psychiatry. 2013 Aug;52(8):841-850.e2
pubmed: 23880494
Qual Life Res. 2018 Sep;27(9):2453-2458
pubmed: 29872956
J Pediatr Psychol. 2014 Mar;39(2):151-62
pubmed: 23836191
J Child Psychol Psychiatry. 2020 Feb;61(2):157-166
pubmed: 31449335
Pediatrics. 2020 Dec;146(6):
pubmed: 33172920
Pediatrics. 1987 Mar;79(3):343-50
pubmed: 3822634
Psychol Assess. 2021 Jul;33(7):610-618
pubmed: 34060864
JAMA Pediatr. 2021 Jun 1;175(6):567-576
pubmed: 33720329
J Affect Disord. 2016 Nov 15;205:327-334
pubmed: 27566452
J Abnorm Child Psychol. 2016 Feb;44(2):393-404
pubmed: 25832625
Pediatr Res. 2022 Nov;92(5):1255-1261
pubmed: 34035428
J Affect Disord. 2011 May;130(3):385-94
pubmed: 21112641
JAMA Netw Open. 2022 Dec 1;5(12):e2247330
pubmed: 36525271
Psychol Bull. 2013 Nov;139(6):1342-96
pubmed: 23566018
Child Psychiatry Hum Dev. 2012 Aug;43(4):511-22
pubmed: 22271225
J Am Acad Child Adolesc Psychiatry. 2010 Nov;49(11):1117-24
pubmed: 20970699
J Pediatr. 2018 Feb;193:85-92.e1
pubmed: 29254758
Behav Genet. 2016 May;46(3):334-52
pubmed: 27075497
Alcohol. 2017 Aug;62:49-60
pubmed: 28755751